- Dubai Fear is 'Noise'—Stay Fully Invested: Strategist
- Buy or Hold: Analyst Rates 10 Retail Stocks
- My Commodities Outlook after Dubai: Dennis Gartman
- Portfolio Prep for Next Week: 'Don't Get Crazy'
- Strategists on Dubai: Avoid 'Rash Moves' Now
- Dubai Stock Market Fear Has 'Legs': Dennis Gartman
- Surprising Options Trades in TiVo Shares
- 10 Dividend Picks For Your Portfolio: Chief Investors
- 4 Thanksgiving Week Buys For Your Portfolio: Market Pros
- There's a 'Great Chance' For a Double-Dip Recession: Strategist
MOST SHARED
- Dubai Stocks Shed 7%, Abu Dhabi Tumbles 8%
- US Senator Opposes Fed Chief Bernanke Renomination
- South Korea Sees Exports Bouncing, but Risks Remain
- Governments Must Take Steps To Avoid More Dubais: El-Erian
- Dubai's Nakheel Seeks Suspension $5.25 Billion in Bonds
- Black Friday Sales Disappoint Investors; Amazon Up
- Tiger Woods Wants to Protect Family Privacy: Agent
- Dubai is Harsh Reminder of Prolonged Global Recovery
- BofA Aims to Clearly Spell Out Credit Card Terms
- Dubai Fear is 'Noise'—Stay Fully Invested: Strategist
- Tech Comes to Holiday Shopping's Rescue?
- Timeless and Time-Tested Warren Buffett Watch Predictions
- Roginsky: The Botax Whose Time Has Come
- Buy or Hold: Analyst Rates 10 Retail Stocks
- Execs: Tis The Season To Take Control
- November Winners & Losers
- Farrell: Testing Those International Waters Again
- Bob Doll: “We Continue to See Gains”
- Midwest Factory Activity Rose in October: Chicago Fed
- US to Push Mortgage Lenders to Modify More Loans
- Cyber Monday: The Last Vestige of Dotcom Hype
- Governments Must Act to Avoid More Dubais: El-Erian
- Regulators Compile Global List of 'Systemic Risk' Banks
- Dubai Stocks Shed 7%, Abu Dhabi Tumbles 8%
- The World's Biggest Debtor Nations
- Scientists Gone Wild: Climate Debate Turns Nasty
- BofA Aims to Clearly Spell Out Credit Card Terms
RSS FEED
CNBC Stock Blog
Text Size 
Size doesn't necessarily matter when it comes to five-star investing. Just ask Frank Sustersic, portfolio manager for Turner Investment Partners.
His small-cap Turner Emerging Growth Fund is up an average of 16.40 percent per year over the last five years. It's currently closed to new investors, but Sustersic is willing to share some of his favorite names.
Recommendations:
Some of his favorite stocks are clinical-research organizations, or CROs.
"They help pharmaceutical companies conduct clinical-research trials," he told CNBC. "All of the companies right now have an amazing tailwind...and currently, there is a pretty significant outsourcing trend that's occurring; pharmaceutical and biotech companies are trying to change their cost structure to be more flexible."
Two of those CROs are Parexel
[PRXL
Loading...
()
] and Icon
[ICLR
Loading...
()
].
"Over the next three to six months, the stocks could need to consolidate a bit," he cautioned, but added, "Over the long-term period of time, I'm still optimistic about these stocks."
Sustersic also likes Ansys
[ANSS
Loading...
()
].
"Ansys makes (simulation) software used by engineers in product designs," he said. "They have a subscription model, so about 70 percent of their revenue base is recurring via subscription or licensing and maintenance."
(Contd.)
____________________________________
CNBC Stock Intelligence:
____________________________________
He's also enthusiastic about Willbros Group
[WG
Loading...
()
], a producer of large-diameter pipeline for natural-gas and oil companies.
"They recently got some big contract wins up in Canada," he noted. "They're probably sold out for the next year or so."
Rounding out his list -- and maybe, saving the best for last -- is Deckers Outdoor
[DECK
Loading...
()
], maker of the popular UGG brand boots.
"Very controversial, very volatile stock," he said, "It still looks like fantastic visibility going forward."
He said an informal survey of department-store buyers revealed that UGGs was the only apparel or shoe product that really sold well during the last holiday-shopping season.
"If anything, they regretted not ordering more," he said.
Disclosures:
Disclosure information for Frank Sustersic was not immediately available.
Data is a real-time snapshot *Data is delayed at least 15 minutes